Friday 1 June 2018 
12:30 Lunch Symposium (non-CME)


INFANTILE HEMANGIOMAS: NEW INSIGHTS 

Chair: Julie Powell, M.D. 

10 years of propranolol: what have we learned?
Christine Léauté-Labrèze, M.D.

Another central mode of action of betablockers
Claude Knauf, Ph.D.

Early referral of infantile hemangioma: the next challenge
Carine Van der Vleuten, M.D.

Severe forms of infantile hemangioma (efficacy of propranolol, sequelae)

Eulalia Baselga, M.D.

Afbeeldingsresultaat voor pierre fabre dermatology